BTS
KURA icon

BB&T Securities’s Kura Oncology KURA Stock Holding History

BB&T Securities’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$249K Hold
16,425
– – ﹤0.01% 1407
2019
Q2 		$323K Hold
16,425
– – ﹤0.01% 1284
2019
Q1 		$272K Hold
16,425
– – ﹤0.01% 1341
2018
Q4 		$230K Hold
16,425
– – ﹤0.01% 1304
2018
Q3 		$287K Buy
16,425
+425
+3% +$8.15K ﹤0.01% 1336
2018
Q2 		$291K Buy
+16,000
New +$271K ﹤0.01% 1292

Other funds holding KURA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

BB&T Securities's KURA Position: Q3 2019 in Review

BB&T Securities held its Kura Oncology (KURA) position steady in Q3 2019 at 16,425 shares worth $249K. The position accounts for ﹤0.01% of the portfolio, ranked #1407.

BB&T Securities first reported a position in KURA in Q2 2018 and has held it in 6 quarters since. The position peaked at $323K in Q2 2019. 116 funds tracked by Wall St. Rank hold KURA as of Q3 2019.

  • BB&T Securities held 16,425 shares of Kura Oncology worth $249K as of Q3 2019.
  • BB&T Securities left its Kura Oncology share count unchanged in Q3 2019.
  • Kura Oncology made up ﹤0.01% of BB&T Securities's portfolio in Q3 2019, its #1407 holding.
  • BB&T Securities first reported a position in Kura Oncology in Q2 2018 and has held it in 6 quarters since.
  • BB&T Securities's Kura Oncology position peaked at $323K in Q2 2019.
  • 116 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.